Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 106

1.

Scientific Versus Experiential Evidence: Discourse Analysis of the Chronic Cerebrospinal Venous Insufficiency Debate in a Multiple Sclerosis Forum.

Koschack J, Weibezahl L, Friede T, Himmel W, Makedonski P, Grabowski J.

J Med Internet Res. 2015 Jul 1;17(7):e159. doi: 10.2196/jmir.4103.

2.

Flexible selection of a single treatment incorporating short-term endpoint information in a phase II/III clinical trial.

Stallard N, Kunz CU, Todd S, Parsons N, Friede T.

Stat Med. 2015 Jun 26. doi: 10.1002/sim.6567. [Epub ahead of print]

PMID:
26112909
3.

Memorandum "Open Metadata". Open Access to Documentation Forms and Item Catalogs in Healthcare.

Dugas M, Jöckel KH, Friede T, Gefeller O, Kieser M, Marschollek M, Ammenwerth E, Röhrig R, Knaup-Gregori P, Prokosch HU.

Methods Inf Med. 2015 Jun 25;54(4). [Epub ahead of print]

PMID:
26108979
4.

Improving clinical trials for cardiovascular diseases: a position paper from the Cardiovascular Round Table of the European Society of Cardiology.

Jackson N, Atar D, Borentain M, Breithardt G, van Eickels M, Endres M, Fraass U, Friede T, Hannachi H, Janmohamed S, Kreuzer J, Landray M, Lautsch D, Le Floch C, Mol P, Naci H, Samani NJ, Svensson A, Thorstensen C, Tijssen J, Vandzhura V, Zalewski A, Kirchhof P.

Eur Heart J. 2015 Jun 15. pii: ehv213. [Epub ahead of print]

PMID:
26077039
5.

WITHDRAWN: Anticholinergics for urinary symptoms in multiple sclerosis.

Nicholas RS, Friede T, Hollis S, Young CA.

Cochrane Database Syst Rev. 2015 Jun 5;6:CD004193. doi: 10.1002/14651858.CD004193.pub3.

PMID:
26043867
6.

A systematic review identifies shortcomings in the reporting of crossover trials in chronic painful conditions.

Straube S, Werny B, Friede T.

J Clin Epidemiol. 2015 Apr 30. pii: S0895-4356(15)00206-1. doi: 10.1016/j.jclinepi.2015.04.006. [Epub ahead of print]

PMID:
26008127
7.

Evidence synthesis for count distributions based on heterogeneous and incomplete aggregated data.

Röver C, Andreas S, Friede T.

Biom J. 2015 May 12. doi: 10.1002/bimj.201300288. [Epub ahead of print]

PMID:
25962834
8.

Patients characteristics influencing the longitudinal utilization of steroids in multiple sclerosis--an observational study.

Rommer PS, Buckow K, Ellenberger D, Friede T, Pitschnau-Michel D, Fuge J, Stüve O, Zettl UK; German Multiple Sclerosis Registry of the German National MS Society.

Eur J Clin Invest. 2015 Jun;45(6):587-93. doi: 10.1111/eci.12450. Epub 2015 May 9.

PMID:
25868705
9.

Regression to the mean and predictors of MRI disease activity in RRMS placebo cohorts--is there a place for baseline-to-treatment studies in MS?

Stellmann JP, Stürner KH, Young KL, Siemonsen S, Friede T, Heesen C.

PLoS One. 2015 Feb 6;10(2):e0116559. doi: 10.1371/journal.pone.0116559. eCollection 2015.

10.

Guest editors' introduction. Preface.

Friede T, Henderson R, Hougaard P.

Stat Med. 2014 Dec 30;33(30):5221-2. doi: 10.1002/sim.6362. No abstract available.

PMID:
25487915
11.

Spline-based procedures for dose-finding studies with active control.

Helms HJ, Benda N, Zinserling J, Kneib T, Friede T.

Stat Med. 2015 Jan 30;34(2):232-48. doi: 10.1002/sim.6320. Epub 2014 Oct 16.

12.

Interleukin-2 receptor antagonists for pediatric liver transplant recipients: a systematic review and meta-analysis of controlled studies.

Crins ND, Röver C, Goralczyk AD, Friede T.

Pediatr Transplant. 2014 Dec;18(8):839-50. doi: 10.1111/petr.12362. Epub 2014 Oct 4. Review.

PMID:
25283839
13.

Educating orally anticoagulated patients in drug safety: a cluster-randomized study in general practice.

Vormfelde SV, Abu Abed M, Hua TD, Schneider S, Friede T, Chenot JF.

Dtsch Arztebl Int. 2014 Sep 12;111(37):607-14. doi: 10.3238/arztebl.2014.0607.

14.

Primum non nocere: shared informed decision making in low back pain--a pilot cluster randomised trial.

Patel S, Ngunjiri A, Hee SW, Yang Y, Brown S, Friede T, Griffiths F, Lord J, Sandhu H, Thistlethwaite J, Tysall C, Underwood M.

BMC Musculoskelet Disord. 2014 Aug 21;15:282. doi: 10.1186/1471-2474-15-282.

15.

Cerebrospinal fluid apolipoprotein E concentration and progression of Alzheimer's disease.

Schmidt C, Gerlach N, Peter C, Gherib K, Lange K, Friede T, Zerr I.

J Alzheimers Dis. 2015;43(4):1229-36. doi: 10.3233/JAD-141581.

PMID:
25125466
16.

Work-related outcomes in randomised placebo-controlled pain trials: a systematic review and meta-analysis.

Wolf I, Friede T, Hallier E, Straube S.

J Occup Med Toxicol. 2014 Jul 15;9:25. doi: 10.1186/1745-6673-9-25. eCollection 2014.

17.

CR1 is potentially associated with rate of decline in sporadic Alzheimer's disease.

Schmidt C, Wolff M, von Ahsen N, Lange K, Friede T, Zerr I.

J Clin Neurosci. 2014 Oct;21(10):1705-8. doi: 10.1016/j.jocn.2014.03.015. Epub 2014 Jul 4.

PMID:
24998857
18.

Point and Interval Estimators of the Target Dose in Clinical Dose-Finding Studies with Active Control.

Helms HJ, Benda N, Friede T.

J Biopharm Stat. 2014 Jun 11:1-19. [Epub ahead of print]

PMID:
24918730
19.

Safety relevant knowledge of orally anticoagulated patients without self-monitoring: a baseline survey in primary care.

Chenot JF, Hua TD, Abu Abed M, Schneider-Rudt H, Friede T, Schneider S, Vormfelde SV.

BMC Fam Pract. 2014 May 25;15:104. doi: 10.1186/1471-2296-15-104.

20.

Data-driven treatment selection for seamless phase II/III trials incorporating early-outcome data.

Kunz CU, Friede T, Parsons N, Todd S, Stallard N.

Pharm Stat. 2014 Jul-Aug;13(4):238-46. doi: 10.1002/pst.1619. Epub 2014 May 2.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk